TrialAnnals of the rheumatic diseases2020

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis.

Elsa Vieira-Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.